Stocks
Intra-Cellular Therapies (ITCI) Net debt US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Net debt, bln rub | -200.9 | -628.3 | -386.9 | -571.9 | -481.0 | -461.0 | |||
| Changes by years, y/y, % | -42% | +213% | -38% | +48% | -16% | +6.7% | |||
Intra-Cellular Therapies. Net debt, bln rub
Intra-Cellular Therapies. Net debt, changes, %
Intra-Cellular Therapies (ITCI) Net debt US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Net debt, bln rub | -520.2 | -494.9 | -475.5 | -481.0 | -461.0 | -461.0 | ||
| Changes by years, y/y, % | -30% | -24% | -21% | -16% | -11% | |||
| Changes by quarters, q/q, % | -9% | -5% | -4% | +1% | -4% | |||
